Focus Partners Advisor Solutions’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Focus Partners Advisor Solutions's BMY Position: Q2 2026 in Review
Focus Partners Advisor Solutions reduced its Bristol-Myers Squibb (BMY) stake by 21% in Q2 2026, selling an estimated $1.49M and leaving 96,478 shares worth $5.56M. The position accounts for 0.05% of the portfolio, ranked #176.
Focus Partners Advisor Solutions first reported a position in BMY in Q1 2022 and has held it in 18 quarters since. The position peaked at $7.42M in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Focus Partners Advisor Solutions held 96,478 shares of Bristol-Myers Squibb worth $5.56M as of Q2 2026.
- Focus Partners Advisor Solutions sold 25,929 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.49M.
- Bristol-Myers Squibb made up 0.05% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #176 holding.
- Focus Partners Advisor Solutions first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 18 quarters since.
- Focus Partners Advisor Solutions's Bristol-Myers Squibb position peaked at $7.42M in Q1 2026.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.